Combination of progesterone-receptor antagonist together...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/567 (2006.01) A61K 31/00 (2006.01) A61K 31/138 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2684084

The present invention relates to the combination of the progesterone-receptor antagonist 11.beta.-(4-acetylphenyl)-17.beta.-hydroxy-17.alpha.-(1,1,2,2,2-pentafluoroethyl)-estra-4,9-dien-3-one or a pharmaceutically acceptable derivative or analogue thereof, together with at least one none-steroidal antiestrogen and to the use of said combination for the prophylaxis and treatment of BRCA1- or BRCA2- mediated diseases. None-steroidal antiestrogenes which can be combined together with the progesterone-receptor antagonist 11.beta.-(4-acetylphenyl)-17.beta.-hydroxy-17.alpha.-(1,1,2,2,2-pentafluoroethyl)-estra-4,9-dien-3-one are for example is tamoxifen, raloxifene, droloxifen, toremifen, lasofoxifen, arzoxifen, GW5638, EM-800, idoxifen and basedoxifene.

La présente invention porte sur la combinaison de l'antagoniste du récepteur de progestérone 11.beta.-(4-acétylphényl)-17.beta.-hydroxy-17.alpha.-(1,1,2,2,2-pentafluoroéthyl)- estra-4,9-diène-3-one ou sur un dérivé ou analogue pharmaceutiquement acceptable de celui-ci, conjointement à au moins un anti-AEstrogène non stéroïdien et sur l'utilisation de ladite combinaison pour la prophylaxie et le traitement de maladies à médiation par BRCA1 ou BRCA2. Des anti-AEstrogènes non stéroïdiens qui peuvent être combinés ensemble avec l'antagoniste de récepteur de progestérone 11.beta.-(4-acétylphényl)-17.beta.-hydroxy-17.alpha.-(1,1,2,2,2-pentafluoroéthyl)- estra-4,9-diène-3-one sont par exemple, le tamoxifène, le raloxifène, le droloxifène, le torémifène, le lasofoxifène, l'arzoxifène, le GW5638, l'EM-800, l'idoxifène et le basedoxifène.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of progesterone-receptor antagonist together... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of progesterone-receptor antagonist together..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of progesterone-receptor antagonist together... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1679211

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.